BriaCell Therapeutics Corp.’s (OTCQB: BCTXF) (TSX.V: BCT) Development of Personalized Immunotherapy Focuses on Advanced Breast Cancer

January 22, 2019 12:48:21
  • Experienced management has been involved in over 10 drug approvals
  • Developing Bria-OTS, the first off-the-shelf personalized immunotherapy targeting advanced breast cancer
  • Impressive results in two proof-of-concept clinical trials revealed rapid response rate, repeated following re-treatment, and excellent safety profile for Bria-IMT, BriaCell’s lead clinical candidate
  • Unmet medical needs of advanced breast cancer estimated between $1 billion and $5 billion, depending on treatment stage
  • Developing Bria-OTS along with BriaDX, a companion diagnostic test, offering the ability to match and treat over 99 percent of the patient population with off-the-shelf personalized immunotherapy

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), an immuno-oncology focused biotechnology company, is tackling problems in the cancer immunotherapy space with solutions that focus on off-the-shelf personalized immunotherapy treatments that are expected to be highly effective and safe. BriaCell has been developing Bria-OTS, an off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer. The World Cancer Research Fund of the American Institute for Cancer Research states that breast cancer is the most commonly occurring cancer in women and the second most common cancer overall, with over two million new cases reported in 2018 (

Initial data from a combination study of Bria-IMT and KEYTRUDA (pembrolizumab/Merck) has demonstrated an excellent safety profile, as the company announced at the…

Read More>>

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office